Economic evaluation of adjuvant trastuzumab emtansine in patients with her2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab–based treatment in Canada

T. Younis, A. Lee, M. E. Coombes, N. Bouganim, D. Becker, C. Revil, G. S. Jhuti

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Economic evaluation of adjuvant trastuzumab emtansine in patients with her2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab–based treatment in Canada'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science